Sarcopenia/Sarcopenie
Conditions
Interventions
A beverage (300 mL) containing 6 g of BCAA, 6 g of BCKA- or 30 g of milk protein will be consumed.
Sponsors
Maastricht University
Eligibility
Inclusion criteria
Inclusion criteria: • Healthy males • Age between 65 and 80 y • BMI between 18.5 and 30 kg/m2
Exclusion criteria
Exclusion criteria: • Lactose intolerance • Smoking • Diabetes • Diagnosed GI tract diseases • Arthritic conditions • A history of neuromuscular problems • Any medications known to affect protein metabolism (i.e. corticosteroids, non- steroidal anti-inflammatories, or prescription strength acne medications). • Use of anticoagulants • Participation in exercise program • Hypertension, high blood pressure that is above 140/90 mmHg • Females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary study parameters include post-prandial plasma amino acid availability and myofibrillar muscle protein synthesis rates. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters include whole-body protein synthesis, breakdown, oxidation, net balance, plasma ammonia, glucose and insulin. | — |
Contacts
Public ContactCas Fuchs
Maastricht University, Dep. Human Biology
Outcome results
None listed